- Home
- Publications
- Publication Search
- Publication Details
Title
Immunologic treatment of Parkinson's disease
Authors
Keywords
-
Journal
Immunotherapy
Volume 10, Issue 2, Pages 81-84
Publisher
Future Medicine Ltd
Online
2017-12-20
DOI
10.2217/imt-2017-0146
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus
- (2017) Hitomi Aono et al. GLIA
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
- (2017) J.A. Obeso et al. MOVEMENT DISORDERS
- T cells from patients with Parkinson’s disease recognize α-synuclein peptides
- (2017) David Sulzer et al. NATURE
- Gut microbiota: Implications in Parkinson's disease
- (2017) Arun Parashar et al. PARKINSONISM & RELATED DISORDERS
- Diagnosis and Management of Parkinson's Disease
- (2017) Joseph Jankovic et al. SEMINARS IN NEUROLOGY
- Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
- (2017) Brian Spencer et al. Acta Neuropathologica Communications
- A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies
- (2017) Jess-Karan S. Dhillon et al. PLoS One
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- New and emerging medical therapies in Parkinson’s disease
- (2016) Mitesh Lotia et al. EXPERT OPINION ON PHARMACOTHERAPY
- Autoimmune atypical parkinsonism — A group of treatable parkinsonism
- (2016) Sudheeran Kannoth et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Targeting α-synuclein: Therapeutic options
- (2016) Benjamin Dehay et al. MOVEMENT DISORDERS
- First-in-human assessment of PRX002, an anti-α-synuclein monoclonal antibody, in healthy volunteers
- (2016) Dale B. Schenk et al. MOVEMENT DISORDERS
- Targeting α-synuclein as a therapeutic strategy for Parkinson’s disease
- (2015) Nada B Lawand et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
- (2015) Benjamin Dehay et al. LANCET NEUROLOGY
- Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy
- (2015) Markus Mandler et al. Molecular Neurodegeneration
- Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials
- (2014) Markus Mandler et al. ACTA NEUROPATHOLOGICA
- Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models
- (2014) D. Games et al. JOURNAL OF NEUROSCIENCE
- A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease
- (2012) Peter Holmans et al. HUMAN MOLECULAR GENETICS
- Movement disorders in autoimmune diseases
- (2012) José Fidel Baizabal-Carvallo et al. MOVEMENT DISORDERS
- Preclinical Biomarkers of Parkinson Disease
- (2011) Yuncheng Wu et al. ARCHIVES OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now